176 related articles for article (PubMed ID: 35882548)
41. Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration.
Maximova N; Maestro A; Zanon D; Marcuzzi A
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32066648
[TBL] [Abstract][Full Text] [Related]
42. Immune checkpoint inhibitor-induced lichenoid drug eruption-sparing scar burns.
Truong K; Chamberlin CV; Kim J; Carlino MS; Araujo RR
Australas J Dermatol; 2024 Mar; 65(2):163-166. PubMed ID: 38009870
[TBL] [Abstract][Full Text] [Related]
43. Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
Cardis MA; Jiang H; Strauss J; Gulley JL; Brownell I
BMC Cancer; 2019 Jun; 19(1):539. PubMed ID: 31164102
[TBL] [Abstract][Full Text] [Related]
44. Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
Siegel J; Totonchy M; Damsky W; Berk-Krauss J; Castiglione F; Sznol M; Petrylak DP; Fischbach N; Goldberg SB; Decker RH; Stamatouli AM; Hafez N; Glusac EJ; Tomayko MM; Leventhal JS
J Am Acad Dermatol; 2018 Dec; 79(6):1081-1088. PubMed ID: 30025829
[TBL] [Abstract][Full Text] [Related]
45. Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.
Montagnon CM; Tolkachjov SN; Murrell DF; Camilleri MJ; Lehman JS
J Am Acad Dermatol; 2021 Jul; 85(1):1-14. PubMed ID: 33684496
[TBL] [Abstract][Full Text] [Related]
46. A case of lichenoid drug eruption associated with sildenafil citratus.
Antiga E; Melani L; Cardinali C; Giomi B; Caproni M; Francalanci S; Fabbri P
J Dermatol; 2005 Dec; 32(12):972-5. PubMed ID: 16471460
[TBL] [Abstract][Full Text] [Related]
47. Captopril-induced lichen planus pemphigoides with pemphigus-like features. A case report.
Flageul B; Foldes C; Wallach D; Vignon-Pennamen MD; Cottenot F
Dermatologica; 1986; 173(5):248-55. PubMed ID: 3542612
[TBL] [Abstract][Full Text] [Related]
48. Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN; Phillips GS; Barrios DM; Wu J; Leung DYM; Moy AP; Kern JA; Lacouture ME
J Am Acad Dermatol; 2020 Nov; 83(5):1255-1268. PubMed ID: 32454097
[TBL] [Abstract][Full Text] [Related]
49. Lichen planus pemphigoides: case report and results of immunofluorescence and immunoelectron microscopic study.
Okochi H; Nashiro K; Tsuchida T; Seki Y; Tamaki K
J Am Acad Dermatol; 1990 Apr; 22(4):626-31. PubMed ID: 2180994
[TBL] [Abstract][Full Text] [Related]
50. Effective treatment of refractory lichen planus pemphigoides with a Janus kinase-1/2 inhibitor.
Moussa A; Colla TG; Asfour L; Bhoyrul B; Sinclair RD
Clin Exp Dermatol; 2022 Nov; 47(11):2040-2041. PubMed ID: 35980165
[TBL] [Abstract][Full Text] [Related]
51. Nivolumab-induced plaque morphea in a malign melanoma patient.
Acar A; Oraloglu G; Yaman B; Karaarslan I
J Cosmet Dermatol; 2021 Aug; 20(8):2645-2647. PubMed ID: 33355973
[TBL] [Abstract][Full Text] [Related]
52. Lichen planus and lichenoid drug eruption after vaccination.
Lai YC; Yew YW
Cutis; 2017 Dec; 100(6):E6-E20. PubMed ID: 29360907
[TBL] [Abstract][Full Text] [Related]
53. Does the bullous eruption of lichen planus pemphigoides recur when the LP relapses?
Saurat JH
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):290-1. PubMed ID: 6371071
[No Abstract] [Full Text] [Related]
54. PD-1 inhibitors induced bullous lichen planus-like reactions: a rare presentation and report of three cases.
Wakade DV; Carlos G; Hwang SJ; Chou S; Hui R; Fernandez-Peñas P
Melanoma Res; 2016 Aug; 26(4):421-4. PubMed ID: 27135655
[TBL] [Abstract][Full Text] [Related]
55. Lichen planus pemphigoides.
Murphy GM; Cronin E
Clin Exp Dermatol; 1989 Jul; 14(4):322-4. PubMed ID: 2686875
[TBL] [Abstract][Full Text] [Related]
56. Lichenoid drug eruption following the Blaschko lines.
Muñoz MA; Pérez-Bernal AM; Camacho FM
Dermatology; 1996; 193(1):66-7. PubMed ID: 8864628
[TBL] [Abstract][Full Text] [Related]
57. Bullous lichen planus and lichen planus pemphigoides--clinico-pathological comparisons.
Gawkrodger DJ; Stavropoulos PG; McLaren KM; Buxton PK
Clin Exp Dermatol; 1989 Mar; 14(2):150-3. PubMed ID: 2598489
[TBL] [Abstract][Full Text] [Related]
58. Lichenoid erythrodermic bullous pemphigoid of the African patient.
Joly P; Tanasescu S; Wolkenstein P; Bocquet H; Gilbert D; Thomine E; Wechsler J; Roujeau JC; Revuz J; Tron F; Lauret P
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):691-7. PubMed ID: 9810884
[TBL] [Abstract][Full Text] [Related]
59. Lichen planus pemphigoides: report of a case with oral lesions.
Allen CM; Camisa C; Grimwood R
Oral Surg Oral Med Oral Pathol; 1987 Feb; 63(2):184-8. PubMed ID: 3547232
[TBL] [Abstract][Full Text] [Related]
60. Coexistence of Lichen Planus Pemphigoides, Palmoplantar Keratoderma of Unna-Thost, and Atopic Dermatitis.
Mokos M; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2022 Sep; 30(2):110-112. PubMed ID: 36254544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
